# An Experimental Study to Compare Treatment Response and Toxicities of Concurrent Chemoradiation With Weekly Cisplatin and Three Weekly Cisplatin in Locally Advanced Head and Neck Cancer.

> **NCT03998696** · PHASE4 · COMPLETED · sponsor: **Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh** · enrollment: 60 (actual)

## Conditions studied

- Head and Neck Squamous Cell Carcinoma

## Interventions

- **DRUG:** Cisplatin 40 mg/m2
- **DRUG:** Cisplatin 100 mg/m2

## Key facts

- **NCT ID:** NCT03998696
- **Lead sponsor:** Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-01
- **Primary completion:** 2018-06-30
- **Final completion:** 2018-12-31
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2019-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03998696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03998696, "An Experimental Study to Compare Treatment Response and Toxicities of Concurrent Chemoradiation With Weekly Cisplatin and Three Weekly Cisplatin in Locally Advanced Head and Neck Cancer.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03998696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*